Triple CFTR Modulator Therapy for Cystic Fibrosis

被引：19
作者：
Holguin, Fernando [1 ]
机构：
[1] Univ Colorado, Div Pulm Sci & Crit Care, Aurora, CO 80045 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 379卷 / 17期
关键词：
IVACAFTOR;
D O I：
10.1056/NEJMe1811996
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1671 / +
页数：2
相关论文
共 10 条
[1]   Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening [J].
Bobadilla, JL ;
Macek, M ;
Fine, JP ;
Farrell, PM .
HUMAN MUTATION, 2002, 19 (06) :575-606
[2]   VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles [J].
Davies, J. C. ;
Moskowitz, S. M. ;
Brown, C. ;
Horsley, A. ;
Mall, M. A. ;
McKone, E. F. ;
Plant, B. J. ;
Prais, D. ;
Ramsey, B. W. ;
Taylor-Cousar, J. L. ;
Tullis, E. ;
Uluer, A. ;
McKee, C. M. ;
Robertson, S. ;
Shilling, R. A. ;
Simard, C. ;
Van Goor, F. ;
Waltz, D. ;
Xuan, F. ;
Young, T. ;
Rowe, S. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (17) :1599-1611
[3]   Mucus clearance and lung function in cystic fibrosis with hypertonic saline [J].
Donaldson, SH ;
Bennett, WD ;
Zeman, KL ;
Knowles, MR ;
Tarran, R ;
Boucher, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (03) :241-250
[4]   Cystic fibrosis [J].
Elborn, J. Stuart .
LANCET, 2016, 388 (10059) :2519-2531
[5]   EFFECT OF AEROSOLIZED RECOMBINANT HUMAN DNASE ON EXACERBATIONS OF RESPIRATORY SYMPTOMS AND ON PULMONARY-FUNCTION IN PATIENTS WITH CYSTIC-FIBROSIS [J].
FUCHS, HJ ;
BOROWITZ, DS ;
CHRISTIANSEN, DH ;
MORRIS, EM ;
NASH, ML ;
RAMSEY, BW ;
ROSENSTEIN, BJ ;
SMITH, AL ;
WOHL, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (10) :637-642
[6]   CFTR Modulator Therapy for Cystic Fibrosis [J].
Grasemann, Hartmut .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21) :2085-2088
[7]   VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles [J].
Keating, Dominic ;
Marigowda, Gautham ;
Burr, Lucy ;
Daines, Cori ;
Mall, Marcus A. ;
McKone, Edward F. ;
Ramsey, Bonnie W. ;
Rowe, Steven M. ;
Sass, Laura A. ;
Tullis, Elizabeth ;
McKee, Charlotte M. ;
Moskowitz, Samuel M. ;
Robertson, Sarah ;
Savage, Jessica ;
Simard, Christopher ;
Van Goor, Fredrick ;
Waltz, David ;
Xuan, Fengjuan ;
Young, Tim ;
Taylor-Cousar, Jennifer L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (17) :1612-1620
[8]   A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation [J].
Ramsey, Bonnie W. ;
Davies, Jane ;
McElvaney, N. Gerard ;
Tullis, Elizabeth ;
Bell, Scott C. ;
Drevinek, Pavel ;
Griese, Matthias ;
McKone, Edward F. ;
Wainwright, Claire E. ;
Konstan, Michael W. ;
Moss, Richard ;
Ratjen, Felix ;
Sermet-Gaudelus, Isabelle ;
Rowe, Steven M. ;
Dong, Qunming ;
Rodriguez, Sally ;
Yen, Karl ;
Ordonez, Claudia ;
Elborn, J. Stuart .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) :1663-1672
[9]   Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del [J].
Taylor-Cousar, Jennifer L. ;
Munck, Anne ;
McKone, Edward F. ;
van der Ent, Cornelis K. ;
Moeller, Alexander ;
Simard, Christopher ;
Wang, Linda T. ;
Ingenito, Edward P. ;
Mckee, Charlotte ;
Lu, Yimeng ;
Lekstrom-Himes, Julie ;
Elborn, J. Stuart .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21) :2013-2023
[10]   Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR [J].
Wainwright, C. E. ;
Elborn, J. S. ;
Ramsey, B. W. ;
Marigowda, G. ;
Huang, X. ;
Cipolli, M. ;
Colombo, C. ;
Davies, J. C. ;
De Boeck, K. ;
Flume, P. A. ;
Konstan, M. W. ;
McColley, S. A. ;
Mccoy, K. ;
McKone, E. F. ;
Munck, A. ;
Ratjen, F. ;
Rowe, S. M. ;
Waltz, D. ;
Boyle, M. P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03) :220-231
1